Genmab A/S entered into a definitive agreement to acquire ProfoundBio for $1.8 billion.
Goldman Sachs International is acting as sole financial advisor to Genmab in this transaction and Clare O?Brien, Derrick Lott, JB Betker, Ben Gris, Mike Walsh, Larry Crouch, Jason ?Jake? Pratt, Jeff Hoschander, Jonathan Cheng, and Matthew Behrens of Shearman & Sterling LLP, Simmons & Simmons LLP and Kromann Reumert are its legal advisors. BofA Securities, Inc. and Morgan Stanley & Co. LLC are acting as financial advisors to ProfoundBio in this transaction and Cooley LLP, Travers Thorp Alberga and Jun He Law Offices, Julia L. Minitti of Wilson Sonsini Goodrich & Rosati, P.C. are its legal advisors.